Web Results

law.justia.com/cases/federal/district-courts/new-jersey/njdce/2:2011cv01576/255581/40

Mar 30, 2012 ... JAD BARGHOUT et al v. BAYER HEALTHCARE PHARMACEUTICALS et al, No. 2:2011cv01576 - Document 40 (D.N.J. 2012) case opinion ...

insight.rpxcorp.com/lit/gandce-175235-bayer-healthcare-pharmaceuticals-v-river-s-edge-pharmaceuticals

Bayer Healthcare Pharmaceuticals, Inc., et al v. River's Edge Pharmaceuticals, LLC et al. 1:11-cv-01634; Filed: 05/19/2011; Case Updated Daily; Latest Docket ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3319684

Jason Dehn, MPH,1 Mukta Arora, MD,2 Stephen Spellman, MS,1 Michelle ... Recent work by Lee et al. has shown important adverse effects of either allele or ... A subsequent logistic regression comparing only the partially-matched vs. .... Inc.; Baxter International, Inc.; Bayer HealthCare Pharmaceuticals; BloodCenter of ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4057955

Mar 15, 2014 ... ... MD,25 Yi-Bin Chen, MD,26 Brenda W. Cooper, MD,27 Jason Dehn, MPH; CHTC,28 .... 24% vs. 9%; p=0.002)]. Rates of relapse, acute and chronic GVHD and ..... In two small series, Thomson et al. showed no influence of prior ... Inc.; Baxter International, Inc.; Bayer HealthCare Pharmaceuticals; Blood ...

Related Search